Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lyophilized Live Attenuated Varicella Vaccine in Healthy Subjects Aged 13–55 Years
CTR20190324Phase 3Completed
- Sponsor
- Beijing Minhai Biological
- Start
- Sep 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Minhai varicella vaccine in chickenpox, sponsored by Beijing Minhai Biological. Started Sep 2019; status: completed.
02
Drugs
Minhai varicella vaccine
03
Conditions
chickenpox
Beyond the preview
Go deeper on CTR20190324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190324.